Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$36.71 - $44.15 $274,150 - $329,712
-7,468 Reduced 86.78%
1,138 $47,000
Q1 2023

May 15, 2023

BUY
$36.81 - $48.12 $274,897 - $359,360
7,468 Added 656.24%
8,606 $355,000
Q4 2022

Feb 14, 2023

SELL
$35.68 - $44.71 $541,943 - $679,100
-15,189 Reduced 93.03%
1,138 $46,000
Q3 2022

Nov 14, 2022

SELL
$42.51 - $54.02 $2.41 Million - $3.06 Million
-56,692 Reduced 77.64%
16,327 $715,000
Q2 2022

Aug 09, 2022

BUY
$46.84 - $59.75 $2.71 Million - $3.46 Million
57,911 Added 383.31%
73,019 $3.59 Million
Q1 2022

May 13, 2022

SELL
$48.09 - $57.79 $87,042 - $104,599
-1,810 Reduced 10.7%
15,108 $856,000
Q4 2021

Feb 09, 2022

BUY
$47.19 - $62.68 $773,632 - $1.03 Million
16,394 Added 3128.63%
16,918 $887,000
Q3 2021

Nov 15, 2021

SELL
$56.91 - $67.81 $500,978 - $596,931
-8,803 Reduced 94.38%
524 $31,000
Q2 2021

Aug 12, 2021

SELL
$64.02 - $71.72 $1.4 Million - $1.56 Million
-21,806 Reduced 70.04%
9,327 $632,000
Q1 2021

May 14, 2021

SELL
$53.26 - $68.08 $194,239 - $248,287
-3,647 Reduced 10.49%
31,133 $2.04 Million
Q4 2020

Feb 11, 2021

BUY
$43.41 - $56.51 $1,258 - $1,638
29 Added 0.08%
34,780 $1.96 Million
Q3 2020

Nov 13, 2020

SELL
$47.43 - $60.75 $32,679 - $41,856
-689 Reduced 1.94%
34,751 $1.69 Million
Q2 2020

Aug 13, 2020

SELL
$43.51 - $66.59 $62,480 - $95,623
-1,436 Reduced 3.89%
35,440 $1.97 Million
Q1 2020

May 14, 2020

BUY
$32.82 - $81.13 $1.2 Million - $2.96 Million
36,466 Added 8894.15%
36,876 $1.87 Million
Q4 2019

Feb 13, 2020

BUY
$60.96 - $77.7 $10,363 - $13,209
170 Added 70.83%
410 $31,000
Q3 2019

Nov 14, 2019

SELL
$55.78 - $68.08 $1.69 Million - $2.07 Million
-30,338 Reduced 99.22%
240 $15,000
Q1 2016

Jul 25, 2019

BUY
N/A
30,578
30,578 $1.49 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.